US 7575742
Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 7575742 (Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/7052